Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2019 Feb 28;12(2):e227216.
doi: 10.1136/bcr-2018-227216.

Neuroleptic malignant syndrome as part of an akinetic crisis associated with sepsis in a patient with Lewy body disease

Affiliations
Case Reports

Neuroleptic malignant syndrome as part of an akinetic crisis associated with sepsis in a patient with Lewy body disease

Saki Manabe et al. BMJ Case Rep. .

Abstract

A 65-year-old Japanese woman with Parkinson's disease, later diagnosed with Lewy body disease, presented with a 2-day history of systemic tremors. She also had fever without rigidity or creatine kinase (CK) elevation. She was diagnosed with sepsis caused by pyelonephritis with acute kidney injury and parkinsonism exacerbation. Although antibiotic and fluid therapy improved her pyuria and renal function, her fever and tremors persisted. On the fourth day, her symptoms worsened and resulted in cardiopulmonary arrest; however, quick resuscitation allowed the return of spontaneous circulation. Simultaneously, hyperthermia, altered consciousness, extrapyramidal symptoms, dysautonomia and CK elevation were noted. Thus, dantrolene administration was initiated with a tentative diagnosis of neuroleptic malignant syndrome (NMS). This caused her fever to subside, and her symptoms gradually improved. It was difficult to distinguish between parkinsonism exacerbation associated with sepsis and NMS. Physicians should consider NMS early on, even if the patient does not fulfil the diagnostic criteria.

Keywords: intensive care; neurology; primary care; psychiatry; unwanted effects / adverse reactions.

PubMed Disclaimer

Conflict of interest statement

Competing interests: None declared.

Figures

Figure 1
Figure 1
Clinical course after admission. CK, creatine kinase; Cr, creatinine; GI, glucose-insulin; K, potassium.

References

    1. Modi S, Dharaiya D, Schultz L, et al. Neuroleptic malignant syndrome: complications, outcomes, and mortality. Neurocrit Care 2016;24:97–103. 10.1007/s12028-015-0162-5 - DOI - PubMed
    1. Strawn JR, Keck PE, Caroff SN. Neuroleptic malignant syndrome. Am J Psychiatry 2007;164:870–6. 10.1176/ajp.2007.164.6.870 - DOI - PubMed
    1. Bonanni L, Di Giacomo R, D’Amico A, et al. Akinetic crisis in dementia with Lewy bodies. J Neurol Neurosurg Psychiatry 2016;87:1123–6. 10.1136/jnnp-2015-312914 - DOI - PubMed
    1. McKeith IG, Dickson DW, Lowe J, et al. Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology 2005;65:1863–72. 10.1212/01.wnl.0000187889.17253.b1 - DOI - PubMed
    1. Levenson JL. Neuroleptic malignant syndrome. Am J Psychiatry 1985;142:1137–45. 10.1176/ajp.142.10.1137 - DOI - PubMed

Publication types